Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.

PMID: 32913286
Journal: BRITISH JOURNAL OF CANCER
Year: 2020
Reference: Br J Cancer. 2020 Nov;123(11):1590-1598. doi: 10.1038/s41416-020-01041-x. Epub 2020 Sep 11.
Impact factor: 5.791
Publication type: Paper in international publication
Authors: Voss, Martin H, Gordon, Michael S, Mita, Monica, Rini, Brian, Makker, Vicky, Macarulla, Teresa, Smith, David C, Cervantes, Andres, Puzanov, Igor, Pili, Roberto et al.
DOI: 10.1038/s41416-020-01041-x

Phase 1b Dose Escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women With HR+, HER2- Advanced Breast Cancer.

PMID: 32998962
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Dec 15;26(24):6417-6428. doi: 10.1158/1078-0432.CCR-20-1068. Epub 2020 Sep 30.
Impact factor: 10.107
Publication type: Paper in international publication
Authors: Rodriguez Lorenc, Cristina K, He, Wei, Su, Fei, Chavez-MacGregor, Mariana, Samant, Tanay, Deshpande, Priya, Han, Yu, Diaz-Padilla, Ivan, Bardia, Aditya, Modi, Shanu et al.
DOI: 10.1158/1078-0432.CCR-20-1068

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.

PMID: 32140889
Journal: INVESTIGATIONAL NEW DRUGS
Year: 2020
Reference: Invest New Drugs. 2020 Oct;38(5):1570-1579. doi: 10.1007/s10637-020-00910-9. Epub 2020 Mar 5.
Impact factor: 3.525
Publication type: Paper in international publication
Authors: Rodon, Jordi, Capper, David, Guba, Susan C, Wang, Shuaicheng, Wick, Antje, Desjardins, Annick, Suarez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Burkholder, Tiana et al.
DOI: 10.1007/s10637-020-00910-9

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.

PMID: 33138866
Journal: BREAST CANCER RESEARCH
Year: 2020
Reference: Breast Cancer Res. 2020 Nov 2;22(1):120. doi: 10.1186/s13058-020-01354-y.
Impact factor: 4.988
Publication type: Paper in international publication
Authors: Villagrasa, Patricia, Li, Yisheng, Savoie, Jennifer, Xu, Zhan, Arteaga, Carlos L, Krop, Ian E, Solit, David B, Mills, Gordon B, Cantley, Lewis C, Winer, Eric P et al.
DOI: 10.1186/s13058-020-01354-y

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

PMID: 32661186
Journal: ESMO Open
Year: 2020
Reference: ESMO Open. 2020 Jul;5(4). pii: esmoopen-2020-000673. doi: 10.1136/esmoopen-2020-000673.
Impact factor: 5.329
Publication type: Paper in international publication
Authors: Wen, Patrick Yung, Rodon, Jordi A, Mason, Warren, Beck, Joseph T, DeGroot, John, Donnet, Valerie, Mills, David, El-Hashimy, Mona, Rosenthal, Mark et al.
DOI: 10.1136/esmoopen-2020-000673

Phase I study of capmatinib in MET-positive solid tumor patients: dose escalation and expansion of selected cohorts.

PMID: 31778267
Journal: CANCER SCIENCE
Year: 2020
Reference: Cancer Sci. 2020 Feb;111(2):536-547. doi: 10.1111/cas.14254. Epub 2019 Dec 30.
Impact factor: 4.966
Publication type: Paper in international publication
Authors: Bang, Yung-Jue, Su, Wu-Chou, Schuler, Martin, Nam, Do-Hyun, Lim, Wan Teck, Bauer, Todd M, Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia-Chi et al.
DOI: 10.1111/cas.14254

Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma.

PMID: 32240793
Journal: ANNALS OF ONCOLOGY
Year: 2020
Reference: Ann Oncol. 2020 Jun;31(6):780-788. doi: 10.1016/j.annonc.2020.03.294. Epub 2020 Mar 30.
Impact factor:
Publication type: Paper in international publication
Authors: Arias, M; Aronchik, I; Brana, I; De Alvaro, J; Di Martino, J; Doger, B; Ferrero, O; Filvaroff, E H; Hanna, B; Hernandez-Guerrero, T et al.
DOI: 10.1016/j.annonc.2020.03.294

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma.

PMID: 32327472
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Jul 15;26(14):3546-3556. doi: 10.1158/1078-0432.CCR-19-3239. Epub 2020 Apr 23.
Impact factor: 10.107
Publication type: Paper in international publication
Authors: Gordon, Leo I, Kaplan, Jason B, Popat, Rakesh, Burris, Howard A, Ferrari, Silvia, Madan, Sumit, Patel, Manish R, Gritti, Giuseppe, El-Sharkawi, Dima, Chau, Ian et al.
DOI: 10.1158/1078-0432.CCR-19-3239

Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer Patients.

PMID: 31540980
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Jan 15;26(2):364-372. doi: 10.1158/1078-0432.CCR-18-3965. Epub 2019 Sep 20.
Impact factor: 10.107
Publication type: Paper in international publication
Authors: Gerber, David E, Infante, Jeffrey R, Gordon, Michael S, Goldberg, Sarah B, Burris, Howard A, Martin, Miguel, Felip, Enriqueta, Martinez Garcia, Maria, Schiller, Joan H, Spigel, David R et al.
DOI: 10.1158/1078-0432.CCR-18-3965

Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations.

PMID: 31395751
Journal: ONCOLOGIST
Year: 2020
Reference: Oncologist. 2020 Jan;25(1):e160-e169. doi: 10.1634/theoncologist.2019-0297. Epub 2019 Aug 8.
Impact factor: 5.025
Publication type: Paper in international publication
Authors: Rodon, Jordi, Janku, Filip, Lolkema, Martijn P, Stephenson, Joe J, Bedard, Philippe L, Schuler, Martin, Sessa, Cristiana, LoRusso, Patricia, Thomas, Michael, Maacke, Heiko et al.
DOI: 10.1634/theoncologist.2019-0297

Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network.

PMID: 32554315
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2020
Reference: Eur J Cancer. 2020 Aug;135:89-97. doi: 10.1016/j.ejca.2020.04.031. Epub 2020 Jun 15.
Impact factor: 7.275
Publication type: Paper in international publication
Authors: Amoroso, Loredana, Castel, Victoria, Bisogno, Gianni, Casanova, Michela, Marquez-Vega, Catalina, Chisholm, Julia C, Doz, Francois, Moreno, Lucas, Ruggiero, Antonio, Gerber, Nicolas U et al.
DOI: 10.1016/j.ejca.2020.04.031

Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).

PMID: 32578279
Journal: EUROPEAN JOURNAL OF CANCER CARE
Year: 2020
Reference: Eur J Cancer Care (Engl). 2020 Jul;29(4):e13253. doi: 10.1111/ecc.13253. Epub 2020 Jun 23.
Impact factor: 2.161
Publication type: Paper in international publication
Authors: Ciruelos, Eva M, Montano, Alvaro, Rodriguez, Cesar A, Gonzalez-Flores, Encarnacion, Lluch, Ana, Garrigos, Laia, Quiroga, Vanesa, Anton, Antonio, Malon, Diego, Chacon, Jose I et al.
DOI: 10.1111/ecc.13253

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.

PMID: 31959756
Journal: Nature Communications
Year: 2020
Reference: Nat Commun. 2020 Jan 20;11(1):385. doi: 10.1038/s41467-019-14111-3.
Impact factor: 12.121
Publication type: Paper in international publication
Authors: Braso-Maristany, Fara, Griguolo, Gaia, Pascual, Tomas, Pare, Laia, Nuciforo, Paolo, Llombart-Cussac, Antonio, Bermejo, Begona, Oliveira, Mafalda, Morales, Serafin, Martinez, Noelia et al.
DOI: 10.1038/s41467-019-14111-3

Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.

PMID: 31678289
Journal: Journal of Allergy and Clinical Immunology-In Practice
Year: 2020
Reference: J Allergy Clin Immunol Pract. 2020 Mar;8(3):971-979.e1. doi: 10.1016/j.jaip.2019.10.017. Epub 2019 Oct 31.
Impact factor: 7.574
Publication type: Paper in international publication
Authors: Lindstrom, Irmeli, Sastre, Joaquin, Walusiak-Skorupa, Jolanta, Munoz, Xavier, Talini, Donatella, Klusackova, Pavlina, Moore, Vicky, Merget, Rolf, Svanes, Cecilie, Mason, Paola et al.
DOI: 10.1016/j.jaip.2019.10.017

Phlebotonics for venous insufficiency.

PMID: 33141449
Journal: Cochrane Database of Systematic Reviews
Year: 2020
Reference: Cochrane Database Syst Rev. 2020 Nov 3;11:CD003229. doi: 10.1002/14651858.CD003229.pub4.
Impact factor: 7.89
Publication type: Review in international publication
Authors: Martinez-Zapata, Maria Jose, Vernooij, Robin Wm, Simancas-Racines, Daniel, Uriona Tuma, Sonia Maria, Stein, Airton T, Moreno Carriles, Rosa Maria M, Vargas, Emilio, Bonfill Cosp, Xavier et al.
DOI: 10.1002/14651858.CD003229.pub4

Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis.

PMID: 32634742
Journal: iScience
Year: 2020
Reference: iScience. 2020 Jul 24;23(7):101306. doi: 10.1016/j.isci.2020.101306. Epub 2020 Jun 24.
Impact factor: 4.447
Publication type: Paper in international publication
Authors: Takubo, Keiyo, Mikawa, Takumi, Shibata, Eri, Shimada, Midori, Ito, Ken, Ito, Tomiko, Kanda, Hiroaki, Yokode, Masayuki, Kondoh, Hiroshi, Inagaki, Nobuya et al.
DOI: 10.1016/j.isci.2020.101306

Pilot study of the multicentre DISCHARGE Trial: image quality and protocol adherence results of computed tomography and invasive coronary angiography.

PMID: 31844958
Journal: EUROPEAN RADIOLOGY
Year: 2020
Reference: Eur Radiol. 2020 Apr;30(4):1997-2009. doi: 10.1007/s00330-019-06522-z. Epub 2019 Dec 16.
Impact factor: 4.101
Publication type: Paper in international publication
Authors: Knuuti, Juhani, De Rubeis, Gianluca, Ball, Peter, Dodd, Jonathan, Hensey, Mark, Mancone, Massimo, Ceccacci, Andrea, Berzina, Marina, Zvaigzne, Ligita, Sakalyte, Gintare et al.
DOI: 10.1007/s00330-019-06522-z

Planning for the assistance of critically ill patients in a Pandemic Situation: The experience of Vall d'Hebron University Hospital.

PMID: 33010961
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2020
Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2020 Sep 8. pii: S0213-005X(20)30272-X. doi: 10.1016/j.eimc.2020.08.007.
Impact factor: 1.654
Publication type: Paper in national publication
Authors: Ferrer, Ricard, Baguena, Marcelino, Balcells, Joan, Baneras, Jordi, Biarnes, Alfons, de Nadal, Miriam, Gracia, Rosa Maria, Martinez, Jesus, Nuvials, Xavier, Riera, Jordi et al.
DOI: 10.1016/j.eimc.2020.08.007

Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.

PMID: 32518978
Journal: JOURNAL OF NEUROLOGY
Year: 2020
Reference: J Neurol. 2020 Oct;267(10):3021-3037. doi: 10.1007/s00415-020-09932-y. Epub 2020 Jun 9.
Impact factor: 3.956
Publication type: Review in international publication
Authors: Cox, Dermot, Lim, Soon Tjin, Thijs, Vincent, Murphy, Stephen J X, Fernandez-Cadenas, Israel, Montaner, Joan, Offiah, Chika, Marquardt, Lars, Kelly, Peter J, Bath, Philip M et al.
DOI: 10.1007/s00415-020-09932-y

PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities.

PMID: 32057060
Journal: Nanoscale
Year: 2020
Reference: Nanoscale. 2020 Feb 27;12(8):4988-5002. doi: 10.1039/c9nr10620k.
Impact factor: 6.895
Publication type: Paper in international publication
Authors: Llop, Jordi, Zhang, Yajie, Garcia-Gabilondo, Miguel, Grayston, Alba, Feiner, Irene V J, Anton-Sales, Irene, Loiola, Rodrigo A, Garcia-Dorado, David, Gosselet, Fabien, Rosell, Anna et al.
DOI: 10.1039/c9nr10620k

PLZF-RARalpha, NPM1-RARalpha, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

PMID: 32455804
Journal: Cancers
Year: 2020
Reference: Cancers (Basel). 2020 May 21;12(5). pii: cancers12051313. doi: 10.3390/cancers12051313.
Impact factor: 6.126
Publication type: Review in international publication
Authors: Montesinos, Pau, Sobas, Marta, Talarn-Forcadell, Maria Carme, Martinez-Cuadron, David, Escoda, Lourdes, Garcia-Perez, Maria J, Mariz, Jose, Mela-Osorio, Maria J, Fernandez, Isolda, Alonso-Dominguez, Juan M et al.
DOI: 10.3390/cancers12051313

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era.

PMID: 33148361
Journal: EPIDEMIOLOGY AND INFECTION
Year: 2020
Reference: Epidemiol Infect. 2020 Nov 5;148:e279. doi: 10.1017/S0950268820002708.
Impact factor: 2.152
Publication type: Paper in international publication
Authors: Uriona, S, Campins, M, Munoz-Almagro, C, Salleras, L, Dominguez, A, Planes, A M, Codina, G, Gonzalez-Peris, S, Fernandez de Sevilla, M, Izquierdo, C et al.
DOI: 10.1017/S0950268820002708

Pneumococcal superinfection in COVID-19 patients: A series of 5 cases.

PMID: 32591180
Journal: MEDICINA CLINICA
Year: 2020
Reference: Med Clin (Barc). 2020 Dec 11;155(11):502-505. doi: 10.1016/j.medcli.2020.05.022. Epub 2020 Jun 5.
Impact factor: 1.635
Publication type: Letter or abstract
Authors: Cucchiari, David, Pericas, Juan M, Riera, Josep, Gumucio, Roberto, Md, Emmanuel Coloma, Nicolas, David et al.
DOI: 10.1016/j.medcli.2020.05.022

Pneumococcal superinfection in COVID-19 patients: A series of 5 cases.

PMID: 33521301
Journal:
Year: 2020
Reference: Med Clin (Engl Ed). 2020 Dec 11;155(11):502-505. doi: 10.1016/j.medcle.2020.05.028. Epub 2020 Dec 14.
Impact factor:
Publication type: Other (letters to the editor, abstracts, corrigendum, etc.)
Authors: Cucchiari, David; Gumucio, Roberto; Md, Emmanuel Coloma; Nicolas, David; Pericas, Juan M; Riera, Josep et al.
DOI: 10.1016/j.medcle.2020.05.028